Dosch Pharmaceuticals Private Limited, a active private limited company, was established on 07 April 1995 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74110MH1995PTC087284. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹45.65 Cr and a paid-up capital of ₹45.64 Cr.
Formerly known as Dosch Pharmatech Private Limited, Non Destructive Engineering Company Private Limited. It upholds a compliant status. Its leadership includes Ashay Sanjay Doshi (Director), Sanjay Kanaiyalal Doshi (Director), Prachi Sanjay Doshi (Director). Past directors included Ashay Sanjay Doshi, Ramesh Bhogilal Parikh, Sanjay Kanaiyalal Doshi. It holds ₹32.65 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 15 C Laxmi Indl Estate New Link Road Andheri West, Mumbai, Maharashtra, 400053.
U74110MH1995PTC087284
087284
07 April 1995
₹45.65 Cr
₹45.64 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Dosch Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashay Sanjay Doshi | Director | 15 Oct 2017 | Current |
| Sanjay Kanaiyalal Doshi | Director | 15 Oct 2017 | Current |
| Prachi Sanjay Doshi | Director | 15 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Director | 15 Nov 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 15 Mar 2021 | Past |
| Pramod Abcsdd | Director | 15 Nov 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dosch Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.16% increase. The company also saw a substantial fall in profitability, with a 54.01% decrease in profit. The company's net worth moved up by a moderate rise of 8.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Dosch Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹326,499,999.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jul 2023 | Others | ₹3.35 Cr | Open |
| 26 May 2023 | Others | ₹2.30 Cr | Open |
| 24 Nov 2015 | Others | ₹27.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dosch Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dosch Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dosch Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dosch Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Dosch Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others of Rs. 2.30 Cr registered on 26 May 2023 with Charge ID 100741025 was modified on 25 Oct 2023. was completed.
The activity A charge with Others amounted to Rs. 3.35 Cr with Charge ID 100743543 was registered on 07 Jul 2023. was completed.
Progress on A charge with Others amounted to Rs. 2.30 Cr with Charge ID 100741025 was registered on 26 May 2023. was documented.
Hemal Bipin Parekh was appointed as a Company Secretary was appointed as a Company Secretary on 01 Dec 2022 & has been associated with this company since 3 years 3 days . was recorded as a recent event.
The CIN of Dosch Pharmaceuticals Private Limited is U74110MH1995PTC087284.
Dosch Pharmaceuticals Private Limited is headquartered at 15 C Laxmi Indl Estate New Link Road Andheri West, Mumbai, Maharashtra, 400053.
Dosch Pharmaceuticals Private Limited was incorporated on 07 April 1995.
The current directors of Dosch Pharmaceuticals Private Limited are
The primary industry of Dosch Pharmaceuticals Private Limited is Manufacturing.
Dosch Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dosch Pharmaceuticals Private Limited is ₹45.65 Cr, and the paid-up capital is ₹45.64 Cr.
The compliance status of Dosch Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX